Abbott Abbott Q4 Diagnostics Revenues Fall 26 Percent on Declining COVID-19 Sales The company announced that its total revenues for the quarter declined 12 percent, while revenues for the full year rose 1 percent. JP Morgan Healthcare Conference, Day 2: Thermo Fisher, Agilent, Roche, Seer, More Highlights from the second day included Agilent's $725 million investment in nucleic acids manufacturing and Roche's development plans for an integrated mass spec platform. Abbott Q3 Diagnostics Revenues Fall 6 Percent Due to COVID-19 Testing Decline Premium The firm's core laboratory revenues fell 6 percent, while molecular sales were down 47 percent. Abbott Gets FDA Emergency Use Authorization for Monkeypox PCR Test The FDA granted authorization for the Alinity m MPXV assay, Abbott's real-time PCR test using human lesion swab specimens. In Brief This Week: Thermo Fisher Scientific, DNAnexus, Precipio, Delfi Diagnostics, Streck, More News items for the week of Sept. 12, 2022. Jul 20, 2022 Continued COVID-19 Test Demand Lifts Abbott Q2 Dx Revenues up 33 Percent Premium May 16, 2022 Abbott Gets FDA Emergency Use Authorization for Point-of-Care COVID-19 Test May 4, 2022 Abbott Nabs FDA Clearance for Multiplex Molecular STI Panel Apr 22, 2022 Nutromics Eyes Clinical Applications for Electrochemical Continuous Molecular Monitoring Platform Premium Apr 20, 2022 Abbott Focusing on Base Business Recovery, but COVID-19 Testing Remains Crucial Revenue Source Premium Apr 20, 2022 Abbott Q1 Diagnostics Revenues Climb 32 Percent Apr 6, 2022 As COVID-19 Sales Retreat, Diagnostic Firms Turn Attention to Core Businesses Premium Jan 27, 2022 Abbott Preparing for COVID-19 Testing Uncertainty in 2022 Premium Jan 26, 2022 Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Jan 12, 2022 JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More Dec 10, 2021 People in the News: New Appointments at NIH, Abbott, Talis Biomedical, More Oct 21, 2021 Abbott Sees Continued Demand for SARS-CoV-2 Rapid Tests Despite Expected Decline in Cases Premium Oct 20, 2021 Abbott Q3 Diagnostics Revenues Rise 48 Percent on Core Lab, Rapid Diagnostics Sales Growth Oct 14, 2021 FDA Classifies Abbott SARS-CoV-2 Molecular Test Recall as Class I Due to False Positives Sep 17, 2021 FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests Jul 22, 2021 Abbott Q2 Diagnostics Revenues Rise 63 Percent on COVID-19 Testing Demand Jun 1, 2021 Abbott Lowers FY21 Guidance as It Sees Sharp Decline in COVID-19 Test Revenue Apr 20, 2021 Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing Mar 11, 2021 Abbott Forms Global Coalition to Monitor, Prevent Future Pandemics Mar 5, 2021 Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.